Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RPL34 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101928000 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SYNGR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RDH10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PMF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASSF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAP1GDS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UCHL5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CENPL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMCO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPRD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF32 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBAP2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SDHC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDUFC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAD2L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on